Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1990 1
1993 1
1999 1
2001 3
2002 1
2005 3
2006 2
2008 1
2009 1
2010 1
2012 1
2019 1
2020 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Major depressive disorder.
Belmaker RH, Agam G. Belmaker RH, et al. N Engl J Med. 2008 Jan 3;358(1):55-68. doi: 10.1056/NEJMra073096. N Engl J Med. 2008. PMID: 18172175 Review. No abstract available.
Subtyping major depressive disorder.
Lichtenberg P, Belmaker RH. Lichtenberg P, et al. Among authors: belmaker rh. Psychother Psychosom. 2010;79(3):131-5. doi: 10.1159/000286957. Epub 2010 Feb 20. Psychother Psychosom. 2010. PMID: 20185969 No abstract available.
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP. Guu TW, et al. Among authors: belmaker rh. Psychother Psychosom. 2019;88(5):263-273. doi: 10.1159/000502652. Epub 2019 Sep 3. Psychother Psychosom. 2019. PMID: 31480057
Major depressive disorder (MDD) is a complex mental illness with unmet therapeutic needs. ...
Major depressive disorder (MDD) is a complex mental illness with unmet therapeutic needs. ...
A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder.
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP. Guu TW, et al. Among authors: belmaker rh. J Affect Disord. 2020 Mar 15;265:233-238. doi: 10.1016/j.jad.2020.01.050. Epub 2020 Jan 15. J Affect Disord. 2020. PMID: 32090746
INTRODUCTION: Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are recommended as an integrative treatment for major depressive disorder (MDD). In 2019, the International Society for Nutritional Psychiatry Research (ISNPR) developed the first practice guidelin …
INTRODUCTION: Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are recommended as an integrative treatment for major depressive …
Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder.
Nemets B, Bersudsky Y, Belmaker RH. Nemets B, et al. Among authors: belmaker rh. J Clin Psychiatry. 2005 May;66(5):586-90. doi: 10.4088/jcp.v66n0507. J Clin Psychiatry. 2005. PMID: 15889944 Clinical Trial.
We therefore undertook a controlled trial of phenytoin versus fluoxetine in major depressive disorder. METHOD: Data were collected from July 2001 to July 2003. Thirty-three subjects entered the study. All patients met DSM-IV criteria for major depre …
We therefore undertook a controlled trial of phenytoin versus fluoxetine in major depressive disorder. METHOD: Data wer …
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Nemets H, et al. Among authors: belmaker rh. Am J Psychiatry. 2006 Jun;163(6):1098-100. doi: 10.1176/ajp.2006.163.6.1098. Am J Psychiatry. 2006. PMID: 16741212 Clinical Trial.
OBJECTIVE: Major depressive disorder in children may be more common than previously thought, and its therapeutics are unclear. Because of success in a previous study on omega-3 fatty acids in adult major depressive disorder, the authors p …
OBJECTIVE: Major depressive disorder in children may be more common than previously thought, and its therapeutics are u …
Omega-3 fatty acids in depression: a review of three studies.
Osher Y, Belmaker RH. Osher Y, et al. Among authors: belmaker rh. CNS Neurosci Ther. 2009 Summer;15(2):128-33. doi: 10.1111/j.1755-5949.2008.00061.x. CNS Neurosci Ther. 2009. PMID: 19499625 Free PMC article. Review.
The first study examined eicosapentaenoic acid (EPA) versus placebo as an adjunct to antidepressant treatment in 20 unipolar patients with recurrent major depression. The second study used omega-3 fatty acids in childhood major depression; 28 children aged 6-12 were …
The first study examined eicosapentaenoic acid (EPA) versus placebo as an adjunct to antidepressant treatment in 20 unipolar patients with r …
Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.
Kofman O, Belmaker RH. Kofman O, et al. Among authors: belmaker rh. Biol Psychiatry. 1993 Dec 15;34(12):839-52. doi: 10.1016/0006-3223(93)90052-f. Biol Psychiatry. 1993. PMID: 8110911 Review.
A higher dose of inositol markedly reduced Hamilton Depression Ratings in 9 of 11 unipolar major depressive disorder patients previously unresponsive to tricyclics, in an open design, but had no effect on chronic schizophrenics in a controlled double-blind ra …
A higher dose of inositol markedly reduced Hamilton Depression Ratings in 9 of 11 unipolar major depressive disorder pa …
Corrigendum to "A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder". [J Affect Disord. 15 (2020) 233-238].
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP. Guu TW, et al. Among authors: belmaker rh. J Affect Disord. 2020 Sep 1;274:1226-1227. doi: 10.1016/j.jad.2020.06.007. Epub 2020 Jun 22. J Affect Disord. 2020. PMID: 32663964 No abstract available.
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder.
Nemets B, Stahl Z, Belmaker RH. Nemets B, et al. Among authors: belmaker rh. Am J Psychiatry. 2002 Mar;159(3):477-9. doi: 10.1176/appi.ajp.159.3.477. Am J Psychiatry. 2002. PMID: 11870016 Clinical Trial.
OBJECTIVE: Studies have reported that countries with high rates of fish oil consumption have low rates of depressive disorder. The authors studied a specific omega-3 fatty acid, the ethyl ester of eicosapentaenoic acid (E-EPA), as an adjunct to treatment for depr …
OBJECTIVE: Studies have reported that countries with high rates of fish oil consumption have low rates of depressive disorder. …
20 results